Rallis India FY26 Revenue Up 9% to ₹2,897 Crore, PAT at ₹184 Crore
Rallis India reported FY26 revenue of ₹2,897 crore, up 9% YoY, with PAT at ₹184 crore compared to ₹125 crore. EBITDA reached ₹362 crore, an increase from the previous year. The company launched new products in Crop Care and Seeds, and saw strong growth in B2B Exports and Seeds businesses.
The announcement details strong financial results for the full fiscal year, including revenue growth, record EBITDA, and a substantial increase in PAT. These are material financial events that directly impact investor perception and the company's valuation.
The company reported significant year-on-year growth in revenue and profit after tax, along with record EBITDA. Strategic business segment growth and new product launches indicate a positive financial performance and outlook.
Rallis India Limited has announced its audited financial results for the quarter and financial year ended March 31, 2026. For the full fiscal year 2025-26, the company reported a 9% revenue growth, reaching ₹2,897 crore compared to ₹2,663 crore in the previous year. This growth was driven by strong performance across its Crop Care, Seeds, and B2B businesses. The company also achieved its highest-ever EBITDA of ₹362 crore, with improved EBITDA margins of 12.5%.
Profit After Tax (PAT) for FY26 stood at ₹184 crore, a significant increase from ₹125 crore in the prior year. The Crop Care business grew by 8% in FY26, with the domestic formulations business contributing 5% growth. The B2B Exports business, including Custom Synthesis Manufacturing (CSM), saw a substantial 17% growth, supported by volume expansion and improved realisations. The Soil and Plant Health (SPH) segment grew by 8%, despite regulatory challenges.
The Seeds business demonstrated robust growth of 15% in FY26, attributed to strategic planning and execution. During the fourth quarter of FY26 (Q4 FY26), Rallis India recorded a revenue of ₹456 crore, a 6% year-on-year increase from ₹430 crore in Q4 FY25. This quarterly growth was driven by a 5% volume increase and a 1% price increase. The Crop Care business saw a 5% growth in Q4 FY26, with the B2C segment growing by 15% while the B2B segment declined by 7%. The Seeds business achieved a strong 23% growth during the quarter.
Key highlights for Q4 FY26 include the launch of two new insecticide products, Fiplam and Alstor, in Crop Protection, and two new products in the Seeds business. The company also achieved its highest-ever production levels for select products and continued its focus on digital initiatives to enhance farmer and retailer engagement.
Dr. Gyanendra Shukla, Managing Director & CEO, Rallis India Limited, commented that FY26 reflects the company's continued focus on strengthening the business through execution, portfolio expansion, and customer engagement. He added that the company will continue to build on its product portfolio, digital capabilities, and innovation pipeline to drive sustainable growth.
What to do with a filing like this
Rallis India Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Rallis India Limited. Read the original for the full detail.